TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Kubator Therapeutics AB
Closing information (x1000 EUR)
Closing information | 2024/01 | 2023/01 | 2022/01 |
Turnover | 233 | 260 | 228 |
Financial expenses | 39 | 6 | 0 |
Earnings before taxes | 127 | 154 | 78 |
EBITDA | 154 | 150 | 74 |
Total assets | 458 | 384 | 316 |
Current assets | 314 | 230 | 163 |
Current liabilities | 187 | 130 | 178 |
Equity capital | 243 | 236 | 123 |
- share capital | 4 | 4 | 5 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2024/01 | 2023/01 | 2022/01 |
Solvency | 53.1% | 61.5% | 38.9% |
Turnover per employee | 233 | 260 | 228 |
Profit as a percentage of turnover | 54.5% | 59.2% | 34.2% |
Return on assets (ROA) | 36.2% | 41.7% | 24.7% |
Current ratio | 167.9% | 176.9% | 91.6% |
Return on equity (ROE) | 52.3% | 65.3% | 63.4% |
Change turnover | -27 | 48 | 70 |
Change turnover % | -10% | 22% | 44% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2024/01 | 2023/01 | 2022/01 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.